Answers are grounded in this paper and cite their sources.
Patients with oncological diseases are very vulnerable to the action of psychological, physical and toxic stressors, requiring active monitoring by a multidisciplinary team. Quality of life and general well-being depend largely on early detection and the integration into case management of all aspects that influence the physical and mental health of these patients. In the context of the development of liaison psychiatry and psycho-oncology, this literature review emphasizes the importance of introducing psychotropic medication as soon as possible in combination with palliative medication to increase the quality of life of the terminally ill cancer patient. Based on the existing data in the literature, the main symptoms that require attention from the mental health specialists integrated into the team that ensures the case management of the oncological patient are pain, sleep disorders, lack of appetite, asthenia, anxiety, and depression. The initiation of psychotropic treatment in patients with oncological conditions must be early and must take into account all the somatic, psychological, social and pharmacological dimensions. In conclusion, the psychiatrist, as part of the multidisciplinary team that provides medical assistance to the oncological patient, is responsible for the early detection of psychiatric symptoms associated with the oncological condition, but also for initiating psychotropic medication as quickly as possible, along with monitoring its effectiveness and tolerability throughout the treatment.
No takes yet. Share an insight, caveat, or question.
Florescu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: